한국어
English
日本語
中文(简体)
Botrient Tablets 400mg (Pazopanib Hydrochloride)
433.4mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Pazopanib hydrochloride is an anticancer ingredient that inhibits the growth of malignant tumors.
MFDS ingredient code M250589
Pazopanib hydrochloride is an anticancer ingredient that acts as a vascular endothelial growth factor inhibitor, primarily used in the treatment of malignant tumors. This ingredient plays a role in blocking the formation of new blood vessels, thereby reducing the nutrient supply to tumors.
Pazopanib hydrochloride prevents the growth of new blood vessels around tumors, reducing the supply of oxygen and nutrients necessary for tumor growth. As a result, the growth of tumor cells is inhibited, and their spread is slowed down.
Approved uses differ by product. Check each product's information for its actual use.
Pazopanib hydrochloride is a multitargeted anticancer agent that simultaneously blocks several vascular endothelial growth factor receptors, inhibiting a broader range of angiogenesis compared to single-target inhibitors. This feature distinguishes it from other anticancer agents.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
